Skip to main content

Keyboard Shortcuts

Key Pair Function
Alt S Search Box
Alt T Top of Page
Alt H Home Page
Alt Index Button
Alt Next Button
Alt Prev Button
TLDEF Logo

TLDEF's Trans Health Project

Working for Transgender Equal Rights
Menu
  • Trans Health Insurance Tutorial
    • Choosing a Plan
    • Understanding Your Plan
    • Applying for Coverage
    • Understanding a Denial
    • Appealing a Denial
  • Resources
    • Health Insurance Medical Policies
    • Medical Organization Statements
    • State Health Insurance Laws and Guidance
    • Medicaid Regulations and Guidance
    • Gender Centers
    • Trans Health Care Providers
    • State Employee Health Plans
    • Financial Aid for Transgender Surgeries
  • Tools
    • Legal Analysis
    • Medical Necessity Literature Reviews
    • Reporting Medical Provider Discrimination
    • Training Materials for Advocates
    • Provider Medical Necessity Letter Checklists
  • About Us
    • About TLDEF's Trans Health Project
    • Privacy Policy
  • Contact Us
    • Contact TLDEF's Trans Health Project
    • Contact TLDEF
Previous Page
Prev
Home
Home
Up
Up
Next Page
Next
  •  Home
  • Resources
  • Medical Organization Statements
  • Current: Pediatric Endocrine Society

Prev Index All Statements [25 of 29] Next

Pediatric Endocrine Society


Download PDF

About the organization:

The Pediatric Endocrine Society (PES) is the leading professional society for this specialty in the United States. The mission of PES is to advance and promote the endocrine health and well-being of children and adolescents. The PES has over 1,400 members representing the multiple disciplines of Pediatric Endocrinology.

The PES Transgender and Gender Non-Conforming Youth Special Interest Group is dedicated to providing safe, comprehensive and evidence based medical care to transgender and gender nonconforming youth.

Statements:

  • Transgender Health Position Statement

    "Medical intervention for transgender youth and adults (including puberty suppression, hormone therapy and medically indicated surgery) is effective, relatively safe (when appropriately monitored), and has been established as the standard of care. Federal and private insurers should cover such interventions as prescribed by a physician as well as the appropriate medical screenings that are recommended for all body tissues that a person may have."

    Date: December 2020

  • Pediatric Endocrine Society/Endocrine Society Joint Position Statement on Transgender Health

    "There is a durable biological underpinning to gender identity that should be considered in policy determinations.

    Medical intervention for transgender youth and adults (including puberty suppression, hormone therapy, and medically indicated surgery) is effective, relatively safe (when appropriately monitored), and has been established as the standard of care.6 Federal and private insurers should cover such interventions as prescribed by a physician as well as the appropriate medical screenings that are recommended for all body tissues that a person may have.

    Increased funding for national pediatric and adult transgender health research programs is needed to close the gaps in knowledge regarding transgender medical care and should be made a priority."

    Date: December 2020

  • Proper Care of Transgender and Gender Diverse Persons in the Setting of Proposed Discrimination: A Policy Perspective

    Abby Walch, Caroline Davidge-Pitts, Joshua D Safer, Ximena Lopez, Vin Tangpricha, Sean J Iwamoto, Proper Care of Transgender and Gender Diverse Persons in the Setting of Proposed Discrimination: A Policy Perspective, The Journal of Clinical Endocrinology & Metabolism, dgaa816, https://doi.org/10.1210/clinem/dgaa816.

    Date: December 2020

  • Discriminatory policies threaten care for transgender, gender diverse individuals

    "The Endocrine Society and the Pediatric Endocrine Society oppose legislative efforts to block transgender and gender diverse individuals from accessing gender-affirming medical and surgical care, the two medical societies said in a joint policy perspective published in The Journal of Clinical Endocrinology & Metabolism."

    Date: December 2020

  • PES Fact Sheet: Introduction to Health for Transgender Youth

    Date: June 17, 2020

  • PES Fact Sheet: Masculinizing Treatment for Transgender Males

    Date: 2018

  • PES Fact Sheet: Feminizing Treatment for Transgender Females

    Date: 2018

  • Statement on Gender Affirmative Approach to Care from the Pediatric Endocrine Society Special Interest Group on Transgender Health

    Ximena Lopez, Maja Marinkovic, Toni Eimicke, Stephen M. Rosenthal & Jerrold S. Olshan, “Statement on gender-affirmative approach to care from the pediatric endocrine society special interest group on transgender health.” Current opinion in pediatrics vol. 29,4 (2017): 475-480. doi:10.1097/MOP.0000000000000516

    "[T]ransgender youth have optimal outcomes when affirmed in their gender identity, through support by their families and their environment, as well as appropriate mental health and medical care. For this reason, the Pediatric Endocrine Society Special Interest Group on Transgender Health joins other academic societies involved in the care of children and adolescents in supporting policies that promote a safe and accepting environment for gender nonconforming/transgender youth, as well as adequate mental health and medical care."

    Date: May 27, 2017

  • PES Statement Promoting Safety of Transgender Youth

    "The Pediatric Endocrine Society (PES), the leading professional society for this specialty in the United States, strongly opposes the guidance issued on February 22, 2017, by the Departments of Justice and Education, which eliminates protection of the rights of transgender youth."

    Date: March 2017

Back to top

Updated on Aug 2, 2022

Donate Now Donate Now

Join Our Mailing List

Facebook Button Twitter Button Instagram Button
 Keyboard Shortcuts
 Privacy Policy
 TLDEF Website

Copyright © 2023 Transgender Legal Defense & Education Fund, Inc.  |  520 8th Avenue, Suite 2204, New York, NY 10018   Tel: 646.862.9396   Fax: 646.993.1684